• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种适用于在对照临床试验中评估移植物通畅性的线性模型。SINBA集团。

A linear model suitable for assessing graft patency in controlled clinical trials. SINBA Group.

作者信息

Marubini E, Montoro C, Mezzanotte G, Petroccione A, Cataldo G, Rovelli F

机构信息

Istituto di Statistica Medica e Biometria, Università di Milano, Italy.

出版信息

Control Clin Trials. 1990 Dec;11(6):420-32. doi: 10.1016/0197-2456(90)90019-x.

DOI:10.1016/0197-2456(90)90019-x
PMID:1963134
Abstract

In clinical trials carried out to assess the efficacy of different drugs in reducing the frequency of occlusion after coronary artery bypass, the ratio of the number of patients with at least one occluded anastomosis to the number of patients catheterized up to a given day is a widely adopted statistic. In the early evaluation (at 1 or 2 months after surgery), this is affected by the distribution of timing of angiography and it tends to underestimate the cumulative probability of occlusion because patients whose anastomoses are all patent at angiography and occlude between angiography and the day at which the ratio is estimated do not contribute their events to the numerator of the ratio. One may sensibly assume that this underestimate does not affect the evaluation of the efficacy of treatments tested "within" the trial. In contrast, since the distributions of the timing of angiography vary substantially from trial to trial, it can make comparisons "between" trials unclear and possibly biased. The aim of this article is to suggest an alternative approach of statistical analysis in terms of logistic regression. By modeling the dichotomous response given by each patient in function of time at angiography, type of treatment, and other possible covariates, asymptotically unbiased estimates of the cumulative probability of occlusion are attained. Furthermore, the pertinent hazard function can be estimated. The main features of the model are discussed and the results obtained by fitting early data collected in the Studio Indobufen Nel Bypass Aortocoronarico (SINBA) are given.

摘要

在评估不同药物降低冠状动脉搭桥术后血管闭塞发生率疗效的临床试验中,截至给定日期,至少有一处吻合口闭塞的患者数量与接受导管检查的患者数量之比是一种广泛采用的统计数据。在早期评估(术后1或2个月)时,这一数据受血管造影时间分布的影响,并且往往会低估闭塞的累积概率,因为血管造影时吻合口均通畅但在血管造影与计算该比例之日之间发生闭塞的患者,其事件未计入该比例的分子中。可以合理地假定,这种低估不会影响对试验“内部”所测试治疗效果的评估。相比之下,由于不同试验的血管造影时间分布差异很大,这可能会使试验“之间”的比较不明确且可能产生偏差。本文的目的是提出一种基于逻辑回归的统计分析替代方法。通过对每位患者在血管造影时间、治疗类型及其他可能协变量作用下给出的二分反应进行建模,可以得到闭塞累积概率的渐近无偏估计。此外,还可以估计相关的风险函数。文中讨论了该模型的主要特征,并给出了拟合吲哚布芬在主动脉冠状动脉搭桥术研究(SINBA)中收集的早期数据所得到的结果。

相似文献

1
A linear model suitable for assessing graft patency in controlled clinical trials. SINBA Group.一种适用于在对照临床试验中评估移植物通畅性的线性模型。SINBA集团。
Control Clin Trials. 1990 Dec;11(6):420-32. doi: 10.1016/0197-2456(90)90019-x.
2
Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.吲哚布芬与阿司匹林和双嘧达莫在冠状动脉搭桥术后移植物通畅性方面的比较:一项联合分析的结果
Coron Artery Dis. 1998;9(4):217-22. doi: 10.1097/00019501-199809040-00007.
3
Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).影响冠状动脉大隐静脉移植血管1年通畅率的因素。吲哚布芬在主动脉冠状动脉旁路移植术中的研究(SINBA)。
Circulation. 1993 Nov;88(5 Pt 2):II93-8.
4
Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.吲哚布芬或阿司匹林 - 双嘧达莫抗血小板治疗对冠状动脉旁路移植术后一年移植血管通畅率的影响。
J Thorac Cardiovasc Surg. 1994 Apr;107(4):1146-53.
5
Indobufen: an updated review of its use in the management of atherothrombosis.吲哚布芬:关于其在动脉粥样硬化血栓形成管理中应用的最新综述。
Drugs Aging. 2001;18(5):369-88. doi: 10.2165/00002512-200118050-00007.
6
[The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].吲哚布芬对主动脉冠状动脉搭桥术后1周及1年后通畅率的影响
Cor Vasa. 1993;35(4):162-4.
7
Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.替格瑞洛与阿司匹林预防冠状动脉搭桥术后心血管事件
Heart. 2016 May 15;102(10):763-9. doi: 10.1136/heartjnl-2015-308691. Epub 2016 Feb 18.
8
Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass.
Int Angiol. 1992 Apr-Jun;11(2):106-12.
9
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.冠状动脉搭桥术后氯吡格雷与阿司匹林联用和单用氯吡格雷对移植物通畅率的影响
Ann Thorac Surg. 2009 Jul;88(1):59-62. doi: 10.1016/j.athoracsur.2009.04.024.
10
Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.阿司匹林联合氯吡格雷治疗可增加冠状动脉旁路手术后早期静脉桥通畅率:一项单中心、随机、对照试验。
J Am Coll Cardiol. 2010 Nov 9;56(20):1639-43. doi: 10.1016/j.jacc.2010.03.104.